Garcia-Donas, J <br/><br/>
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 2013 
 - 2409-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdt219  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Basic Helix-Loop-Helix Transcription Factors--biosynthesis<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Hypoxia--drug effects<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression--drug effects<br/>Humans<br/>Hypoxia-Inducible Factor-Proline Dioxygenases--genetics<br/>Immunohistochemistry<br/>Indoles--adverse effects<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Prospective Studies<br/>Pyrroles--adverse effects<br/>RNA, Messenger--biosynthesis<br/>Sunitinib<br/>Survival<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor Receptor-3--biosynthesis